爱尔眼科(300015) - 2018 Q2 - 季度业绩预告

Financial Performance - The company expects a net profit of approximately RMB 48,874.47 million to RMB 52,494.80 million for the reporting period, representing a year-on-year growth of 35% to 45%[3] - The net profit for the same period last year was RMB 36,203.31 million[3] - The increase in net profit is attributed to the expansion of the company's operational scale and successful implementation of international strategies, leading to improved market share and operational efficiency[5] - The estimated impact of non-recurring gains and losses on net profit is around -RMB 2,300 million[7] - The company's brand influence continues to strengthen, contributing to steady growth in revenue and net profit[5] Reporting and Disclosure - The financial data in this earnings forecast has not been audited by a registered accountant[4] - The detailed financial data will be disclosed in the company's 2018 semi-annual report[7] - The reporting period covers January 1, 2018, to June 30, 2018[3] - The earnings forecast is based on preliminary calculations by the company's finance department[7] Investor Guidance - The company emphasizes the importance of rational investment and risk awareness for investors[7]